Biotia
PrivateLast Round
Grant
Jun 17, 2025
Total Funding Raised
$10.4M
Company Overview
Biotia is a health technology company that provides sequencing-based technology and proprietary AI-powered software to identify microorganisms and antimicrobial resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Precision Medicine, Vertical SaaS
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biotia Comparables
Compare Biotia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pathogenomix, Inc. | 88% | |
| Noscendo GmbH | 84% | |
| BugSeq Bioinformatics Inc. | 83% | |
Biotia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 17, 2025 | ||||
| Series A | Aug 23, 2022 | ||||
| Seed | Dec 10, 2019 |
Key People
Founding team and executive leadership
Biotia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Phoenix Venture Partners | Series A |
| SeedtoB Capital | Series A |
| Tau Ventures | Series A |
| SK Square Americas | Series A |
| DigitalDx Ventures | Series A |
| Continuum Health Ventures | Series A |
| SpringTide Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 41% MoM, reaching 3.3K.
- Sep 8, 2025
Launched a new 'test to treat' option for recurrent UTIs.
Biotia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biotia's valuation, stock price, and market status.